{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,29]],"date-time":"2025-06-29T18:40:01Z","timestamp":1751222401266,"version":"3.41.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Urologe"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1007\/s00120-017-0559-1","type":"journal-article","created":{"date-parts":[[2018,1,10]],"date-time":"2018-01-10T13:02:18Z","timestamp":1515589338000},"page":"79-92","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Urosepsis"],"prefix":"10.1007","volume":"57","author":[{"given":"Mathias W.","family":"Pletz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sebastian","family":"Weis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christina","family":"Forstner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florian","family":"Wagenlehner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,1,10]]},"reference":[{"key":"559_CR1","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1164\/rccm.201504-0781OC","volume":"193","author":"C Fleischmann","year":"2016","unstructured":"Fleischmann C, Scherag A, Adhikari NK et al (2016) Assessment of global incidence and mortality of hospital-treated sepsis. Current estimates and limitations. Am J Respir Crit Care Med 193:259\u2013272","journal-title":"Am J Respir Crit Care Med"},{"key":"559_CR2","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1586\/eri.12.50","volume":"10","author":"GS Martin","year":"2012","unstructured":"Martin GS (2012) Sepsis, severe sepsis and septic shock: changes in incidence, pathogens and outcomes. Expert Rev Anti Infect Ther 10:701\u2013706","journal-title":"Expert Rev Anti Infect Ther"},{"key":"559_CR3","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1007\/s00134-006-0517-7","volume":"33","author":"C Engel","year":"2007","unstructured":"Engel C, Brunkhorst FM, Bone HG et\u00a0al (2007) Epidemiology of sepsis in Germany: results from a\u00a0national prospective multicenter study. Intensive Care Med 33:606\u2013618","journal-title":"Intensive Care Med"},{"key":"559_CR4","doi-asserted-by":"crossref","first-page":"9028924","DOI":"10.1155\/2016\/9028924","volume":"2016","author":"XH Qiang","year":"2016","unstructured":"Qiang XH, Yu TO, Li YN et\u00a0al (2016) Prognosis risk of urosepsis in critical care medicine: a prospective observational study. Biomed Res Int 2016:9028924","journal-title":"Biomed Res Int"},{"key":"559_CR5","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","volume":"315","author":"M Singer","year":"2016","unstructured":"Singer M, Deutschman CS, Seymour CW et al (2016) The third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA 315:801\u2013810","journal-title":"JAMA"},{"key":"559_CR6","series-title":"AWMF Leitlinie AWMF RegNo 082-006","volume-title":"S2k Leitline: Kalkulierte parenterale Initialtherapie bakterieller Erkrankungen be Erwachsenen-Update 2017","author":"KF Bodmann","year":"2017","unstructured":"Bodmann KF, Grabein B, EDP-E-GFC EV (2017) S2k Leitline: Kalkulierte parenterale Initialtherapie bakterieller Erkrankungen be Erwachsenen-Update 2017. AWMF Leitlinie AWMF RegNo 082-006."},{"key":"559_CR7","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1007\/s00345-015-1722-1","volume":"34","author":"Z Tandogdu","year":"2016","unstructured":"Tandogdu Z, Bartoletti R, Cai T et\u00a0al (2016) Antimicrobial resistance in urosepsis: outcomes from the multinational, multicenter global prevalence of infections in urology (GPIU) study 2003\u20132013. World J Urol 34:1193\u20131200","journal-title":"World J Urol"},{"key":"559_CR8","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1001\/archinte.1979.03630380056019","volume":"139","author":"PJ Demuth","year":"1979","unstructured":"Demuth PJ, Gerding DN, Crossley K (1979) Staphylococcus aureus bacteriuria. Arch Intern Med 139:78\u201380","journal-title":"Arch Intern Med"},{"key":"559_CR9","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1128\/CMR.05022-11","volume":"25","author":"SJ Hal Van","year":"2012","unstructured":"Van Hal SJ, Jensen SO, Vaska VL et\u00a0al (2012) Predictors of mortality in staphylococcus aureus bacteremia. Clin Microbiol Rev 25:362\u2013386","journal-title":"Clin Microbiol Rev"},{"key":"559_CR10","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1186\/1471-2334-10-225","volume":"10","author":"S Chihara","year":"2010","unstructured":"Chihara S, Popovich KJ, Weinstein RA et al (2010) Staphylococcus aureus bacteriuria as a\u00a0prognosticator for outcome of staphylococcus aureus bacteremia: a\u00a0case-control study. BMC Infect Dis 10:225","journal-title":"BMC Infect Dis"},{"key":"559_CR11","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1093\/cid\/cir034","volume":"52","author":"C Liu","year":"2011","unstructured":"Liu C, Bayer A, Cosgrove SE et al (2011) Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant staphylococcus aureus infections in adults and children: executive summary. Clin Infect Dis 52:285\u2013292","journal-title":"Clin Infect Dis"},{"key":"559_CR12","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1093\/jac\/dkt108","volume":"68","author":"JL Nissen","year":"2013","unstructured":"Nissen JL, Skov R, Knudsen JD et al (2013) Effectiveness of penicillin, dicloxacillin and cefuroxime for penicillin-susceptible staphylococcus aureus bacteraemia: a\u00a0retrospective, propensity-score-adjusted case-control and cohort analysis. J\u00a0Antimicrob Chemother 68:1894\u20131900","journal-title":"J Antimicrob Chemother"},{"key":"559_CR13","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/j.cell.2017.05.031","volume":"169","author":"S Weis","year":"2017","unstructured":"Weis S, Carlos AR, Moita MR et\u00a0al (2017) Metabolic adaptation establishes disease tolerance to sepsis. Cell 169:1263\u20131275","journal-title":"Cell"},{"key":"559_CR14","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1056\/NEJMoa1415236","volume":"372","author":"KM Kaukonen","year":"2015","unstructured":"Kaukonen KM, Bailey M, Pilcher D et\u00a0al (2015) Systemic inflammatory response syndrome criteria in defining severe sepsis. N\u00a0Engl J Med 372:1629\u20131638","journal-title":"N Engl J Med"},{"key":"559_CR15","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1001\/jama.2016.0288","volume":"315","author":"CW Seymour","year":"2016","unstructured":"Seymour CW, Liu VX, Iwashyna TJ et al (2016) Assessment of clinical criteria for sepsis: for the third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA 315:762\u2013774","journal-title":"JAMA"},{"key":"559_CR16","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1164\/rccm.201604-0854OC","volume":"195","author":"MM Churpek","year":"2017","unstructured":"Churpek MM, Snyder A, Han X et al (2017) Quick sepsis-related organ failure assessment, systemic inflammatory response syndrome, and early warning scores for detecting clinical deterioration in infected patients outside the intensive care unit. Am J Respir Crit Care Med 195:906\u2013911","journal-title":"Am J Respir Crit Care Med"},{"key":"559_CR17","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1007\/s00134-017-4683-6","volume":"43","author":"A Rhodes","year":"2017","unstructured":"Rhodes A, Evans LE, Alhazzani W et\u00a0al (2017) Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016. Intensive Care Med 43:304\u2013377","journal-title":"Intensive Care Med"},{"key":"559_CR18","unstructured":"www.survivingsepsis.org. Zugegriffen: 14.12.2017"},{"key":"559_CR19","doi-asserted-by":"crossref","first-page":"R206","DOI":"10.1186\/cc9328","volume":"14","author":"C Nieuwkoop Van","year":"2010","unstructured":"Van Nieuwkoop C, Bonten TN, Van\u2019t Wout JW et\u00a0al (2010) Procalcitonin reflects bacteremia and bacterial load in urosepsis syndrome: a\u00a0prospective observational study. Crit Care 14:R206","journal-title":"Crit Care"},{"key":"559_CR20","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/j.1532-5415.2009.02175.x","volume":"57","author":"KP High","year":"2009","unstructured":"High KP, Bradley SF, Gravenstein S et al (2009) Clinical practice guideline for the evaluation of fever and infection in older adult residents of long-term care facilities: 2008 update by the Infectious Diseases Society of America. J\u00a0Am Geriatr Soc 57:375\u2013394","journal-title":"J Am Geriatr Soc"},{"key":"559_CR21","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1086\/313896","volume":"31","author":"DC Norman","year":"2000","unstructured":"Norman DC (2000) Fever in the elderly. Clin Infect Dis 31:148\u2013151","journal-title":"Clin Infect Dis"},{"key":"559_CR22","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1093\/cid\/cir790","volume":"54","author":"J Rodriguez-Bano","year":"2012","unstructured":"Rodriguez-Bano J, Navarro MD, Retamar P et al (2012) beta-Lactam\/beta-lactam inhibitor combinations for the treatment of bacteremia due to extended-spectrum beta-lactamase-producing Escherichia coli: a\u00a0post hoc analysis of prospective cohorts. Clin Infect Dis 54:167\u2013174","journal-title":"Clin Infect Dis"},{"key":"559_CR23","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1469-0691.2011.03703.x","volume":"19","author":"R Leclercq","year":"2013","unstructured":"Leclercq R, Canton R, Brown DF et\u00a0al (2013) EUCAST expert rules in antimicrobial susceptibility testing. Clin Microbiol Infect 19:141\u2013160","journal-title":"Clin Microbiol Infect"},{"key":"559_CR24","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1093\/cid\/civ003","volume":"60","author":"PD Tamma","year":"2015","unstructured":"Tamma PD, Han JH, Rock C et al (2015) Carbapenem therapy is associated with improved survival compared with piperacillin-tazobactam for patients with extended-spectrum beta-lactamase bacteremia. Clin Infect Dis 60:1319\u20131325","journal-title":"Clin Infect Dis"},{"key":"559_CR25","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S1473-3099(16)30004-4","volume":"16","author":"Y Carmeli","year":"2016","unstructured":"Carmeli Y, Armstrong J, Laud PJ et al (2016) Ceftazidime-avibactam or best available therapy in patients with ceftazidime-resistant Enterobacteriaceae and Pseudomonas aeruginosa complicated urinary tract infections or complicated intra-abdominal infections (REPRISE): a\u00a0randomised, pathogen-directed, phase 3 study. Lancet Infect Dis 16:661\u2013673","journal-title":"Lancet Infect Dis"},{"key":"559_CR26","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1093\/cid\/ciw378","volume":"63","author":"FM Wagenlehner","year":"2016","unstructured":"Wagenlehner FM, Sobel JD, Newell P et al (2016) Ceftazidime-avibactam versus doripenem for the treatment of complicated urinary tract infections, including acute pyelonephritis: RECAPTURE, a\u00a0phase 3 randomized trial program. Clin Infect Dis 63:754\u2013762","journal-title":"Clin Infect Dis"},{"key":"559_CR27","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1016\/S0140-6736(14)62220-0","volume":"385","author":"FM Wagenlehner","year":"2015","unstructured":"Wagenlehner FM, Umeh O, Steenbergen J et al (2015) Ceftolozane-tazobactam compared with levofloxacin in the treatment of complicated urinary-tract infections, including pyelonephritis: a\u00a0randomised, double-blind, phase 3 trial (ASPECT-cUTI). Lancet 385:1949\u20131956","journal-title":"Lancet"},{"key":"559_CR28","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1093\/jac\/dkw499","volume":"72","author":"C Staley","year":"2017","unstructured":"Staley C, Vaughn BP, Graiziger CT et al (2017) Gut-sparing treatment of urinary tract infection in patients at high risk of clostridium difficile infection. J\u00a0Antimicrob Chemother 72:522\u2013528","journal-title":"J Antimicrob Chemother"},{"key":"559_CR29","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1007\/s00345-013-1218-9","volume":"32","author":"M Cek","year":"2014","unstructured":"Cek M, Tandogdu Z, Wagenlehner F et al (2014) Healthcare-associated urinary tract infections in hospitalized urological patients \u2013 a global perspective: results from the GPIU studies 2003\u20132010. World J Urol 32:1587\u20131594","journal-title":"World J Urol"},{"issue":"11","key":"559_CR30","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1007\/s00134-017-4782-4","volume":"43","author":"F Bloos","year":"2017","unstructured":"Bloos F, Ruddel H, Thomas-Ruddel D et al (2017) Effect of a\u00a0multifaceted educational intervention for anti-infectious measures on sepsis mortality: a\u00a0cluster randomized trial. Intensive Care Med 43(11):1602\u20131612. https:\/\/doi.org\/10.1007\/s00134-017-4782-4","journal-title":"Intensive Care Med"},{"key":"559_CR31","first-page":"317","volume":"83","author":"W Hofmann","year":"1990","unstructured":"Hofmann W (1990) Urosepsis and uroseptic shock. Z\u00a0Urol Nephrol 83:317\u2013324","journal-title":"Z Urol Nephrol"},{"key":"559_CR32","first-page":"837","volume":"112","author":"NM Dreger","year":"2015","unstructured":"Dreger NM, Degener S, Ahmad-Nejad P et al (2015) Urosepsis \u2013 etiology, diagnosis, and treatment. Dtsch Arztebl Int 112:837\u2013847 (quiz 848)","journal-title":"Dtsch Arztebl Int"},{"key":"559_CR33","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1007\/s00120-010-2253-4","volume":"49","author":"FM Wagenlehner","year":"2010","unstructured":"Wagenlehner FM, Lichtenstern C, Weigand MA et\u00a0al (2010) Urosepsis and treatment. Urologe A 49:618\u2013622","journal-title":"Urologe A."},{"key":"559_CR34","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1056\/NEJMoa010307","volume":"345","author":"E Rivers","year":"2001","unstructured":"Rivers E, Nguyen B, Havstad S et al (2001) Early goal-directed therapy in the treatment of severe sepsis and septic shock. N\u00a0Engl J Med 345:1368\u20131377","journal-title":"N Engl J Med"},{"key":"559_CR35","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1186\/s13054-016-1288-3","volume":"20","author":"HB Nguyen","year":"2016","unstructured":"Nguyen HB, Jaehne AK, Jayaprakash N et al (2016) Early goal-directed therapy in severe sepsis and septic shock: insights and comparisons to ProCESS, ProMISe, and ARISE. Crit Care 20:160","journal-title":"Crit Care"}],"container-title":["Der Urologe"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00120-017-0559-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00120-017-0559-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00120-017-0559-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,29]],"date-time":"2025-06-29T18:18:45Z","timestamp":1751221125000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00120-017-0559-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["559"],"URL":"https:\/\/doi.org\/10.1007\/s00120-017-0559-1","relation":{},"ISSN":["0340-2592","1433-0563"],"issn-type":[{"type":"print","value":"0340-2592"},{"type":"electronic","value":"1433-0563"}],"subject":[],"published":{"date-parts":[[2018,1]]}}}